Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 11/20 | 0.53 |
| ▸ | MAOA | P21397 | 2/20 | 0.53 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.53 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.48 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5684098 | 0.80 | MAOB (0.53) | MAOBMAOASCN9APARP10PPARA | |
| SCHEMBL1067948 | 0.78 | MAOB (0.65) | MAOBMAOASCN9APARP10PPARA | |
| SCHEMBL5684175 | 0.77 | MAOB (0.56) | MAOBMAOASCN9APARP10PPARA | |
| SCHEMBL6263243 | 0.75 | SCN3A (0.46) | MAOBMAOASCN9APARP10PPARA | |
| SCHEMBL1069559 | 0.73 | MAOB (0.70) | MAOBMAOASCN9APARP10 | |
| SCHEMBL8083083 | 0.73 | MAOB (0.47) | MAOBMAOASCN9APARP10PPARA | |
| SCHEMBL963386 | 0.72 | SPHK2 (0.67) | MAOBMAOASCN9APARP10PPARA | |
| SCHEMBL5680344 | 0.72 | MAOB (0.49) | MAOBMAOASCN9APARP10 | |
| SCHEMBL8935236 | 0.71 | MAOB (0.63) | MAOBMAOASCN9APARP10PPARA | |
| SCHEMBL3971368 | 0.71 | MAOB (0.58) | MAOBMAOASCN9APARP10PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070276046-A1 | Alpha-Aminoamide Derivatives Useful as Anti-Inflammatory Agents | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2007-11-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070276046-A1 | Alpha-Aminoamide Derivatives Useful as Anti-Inflammatory Agents | IL1A, AADAT, DNPEP | MAOB 1206/4885MAOA 525/4885SCN9A 2253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.